LivaNova LIVN
NASDAQ LIVN
$78.96 -1.74 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

LivaNova (LIVN) Other financing activities (2015 - 2026)

LivaNova's (LIVN) quarterly Other financing activities came in at -$6.0 million in Q2 2026, down 93.72% year-over-year from -$95.9 million in Q2 2025, and down 455.52% quarter-over-quarter from $1.7 million in Q1 2026.

Analysis

LivaNova (LIVN) Other financing activities (2015 - 2026) Analysis & Trends

LivaNova has disclosed Other financing activities across 12 years of filings, most recently posting -$6.0 million for Q2 2026.

  • In Q2 2026, Other financing activities fell 93.72% year-over-year to -$6.0 million; the TTM figure through Jun 2026 stood at -$1.5 million (up 52.08% YoY), while the FY2025 annual figure was -$338000.0, down 101.5% from the prior year.
  • Other financing activities came in at -$6.0 million for Q2 2026 at LivaNova, down from $1.7 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $22.5 million in Q1 2024 to a low of -$6.0 million in Q2 2026.
  • Average Other financing activities over 5 years is $1.5 million, with a median of $488000.0 recorded in 2023.
  • Year-over-year, Other financing activities sank 180.15% in 2023 and surged 11692.15% in 2024.
  • Over 5 years, Other financing activities stood at $1.1 million in 2022, then slumped by 180.15% to -$848000.0 in 2023, then soared by 2756.01% to $22.5 million in 2024, then slumped by 90.97% to $2.0 million in 2025, then sank by 396.06% to -$6.0 million in 2026.
  • Per Business Quant data, the three most recent Other financing activities figures were -$6.0 million in Q2 2026, $1.7 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 LivaNova 4.34 Bn 3.82 Bn 273.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.02 Mn
Mar 31, 2026 1.69 Mn
Dec 31, 2025 2.03 Mn
Sep 30, 2025 782,000.00
Jun 30, 2025 -3.11 Mn
Mar 31, 2025 -46,000.00
Mar 31, 2024 22.52 Mn
Dec 31, 2023 -848,000.00
Sep 30, 2023 1.06 Mn
Jun 30, 2023 194,000.00
Mar 31, 2023 191,000.00
Dec 31, 2022 1.06 Mn
Jun 30, 2022 1.75 Mn
Mar 31, 2022 35,000.00
Dec 31, 2021 2.20 Mn
Sep 30, 2021 497,000.00
Jun 30, 2021 1.95 Mn
Mar 31, 2021 -201,000.00
Dec 31, 2020 986,000.00
Sep 30, 2020 -1,000.00